Nascent Biotech Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
07 Jun 23 | BuyUS$5,200 | Lowell Holden | Individual | 130,000 | US$0.04 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 105,000 | 0.0615% |
Individual Insiders | 76,169,175 | 44.6% |
General Public | 94,319,990 | 55.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
22,934,007 | US$2.3m | 0.99% | no data | |||
21,272,889 | US$2.1m | 0% | no data | |||
11,909,477 | US$1.2m | 0.95% | no data | |||
10,000,000 | US$999.0k | 0% | no data | |||
4,640,625 | US$463.6k | 0% | no data | |||
3,640,625 | US$363.7k | 0% | no data | |||
1,771,552 | US$177.0k | 1.55% | no data | |||
105,000 | US$10.5k | 0% | no data |